What are you looking for?

Are you concerned about the effects of the public health crisis on your potential M&A process and planning? Read our expert M&A piece from dealmakers Miro Parizek and Dr. Jan Eiben.

Part 3 in our blogpost series considers which industries are poised to benefit from the lockdown measures, and which industries are having to revaluate their business models to cope with and adapt to the current situation.

In our fourth and final post of the series, our M&A experts Miro Parizek and Dr. Jan Eiben discuss the next steps for those considering or in the process of a technology transaction, including how to make the most of the current circumstances.

We take a look at five ways the sector is helping to lead the charge against coronavirus, and ask if COVID-19 is healthtech’s opportunity to shine.

We take a look at how AI is proving its mettle during the COVID-19 outbreak, and how it is shaping up to be a crucial ally in achieving a socially distant society.

We take a look at five tech giants that are doing more than weathering the storm, how they are doing it, and, crucially, what might happen next.

As businesses emerge from the COVID crisis we look at how the AI industry is meeting that challenge and how companies are using AI to build COVID-19 resilience.

Computer vision could provide retailers with an invaluable lifeline and a view of the future of retail as the High Street struggles to come to terms with the fall out of the COVID-19 pandemic.

Our latest Artificial Intelligence M&A market report shows that the year 2019 saw more AI deals than across 2017 and 2018 combined.

At Hampleton, we are running a series of webinars to support CEOs and senior management teams who need to understand the impact of COVID-19 on the M&A potential for their company.